speb/financial-data huggingface dataset:
VEON cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 114000000.00
VEON cash_flow (quarterly, 2025-03-31) — Changes In Cash: 72000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Common Stock: 2000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 1207000000.00
VEON cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -24000000.00
VEON income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 129000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Current Assets: 3041000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1696000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 3763000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Current Provisions: 73000000.00
VEON cash_flow (quarterly, 2025-03-31) — Depreciation: 138000000.00
VEON cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 198000000.00
VEON income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 198000000.00
VEON cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 198000000.00
VEON income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 198000000.00
VEON income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 138000000.00
VEON income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 72720000.00
VEON income_statement (quarterly, 2025-03-31) — Diluted EPS: 1.50
VEON income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 99000000.00
VEON income_statement (quarterly, 2025-03-31) — EBIT: 249000000.00
VEON income_statement (quarterly, 2025-03-31) — EBITDA: 447000000.00
VEON cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 5000000.00
VEON cash_flow (quarterly, 2025-03-31) — End Cash Position: 1773000000.00
VEON cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -151000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Foreign Currency Translation Adjustments: -6150000000.00
VEON cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 224000000.00
VEON income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: 0.00
VEON income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -30000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -8117000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1477000000.00
VEON income_statement (quarterly, 2025-03-31) — Gross Profit: 897000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 169000000.00
VEON income_statement (quarterly, 2025-03-31) — Interest Expense: 119000000.00
VEON income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 119000000.00
VEON income_statement (quarterly, 2025-03-31) — Interest Income: 10000000.00
VEON income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 10000000.00
VEON cash_flow (quarterly, 2025-03-31) — Interest Paid Cfo: -59000000.00
VEON cash_flow (quarterly, 2025-03-31) — Interest Received Cfo: 9000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Inventory: 16000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1207000000.00
VEON cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -210000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 62000000.00
VEON cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 89000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 3007000000.00
VEON cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 89000000.00
VEON cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -216000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 51000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Minority Interest: 181000000.00
VEON income_statement (quarterly, 2025-03-31) — Minority Interests: -19000000.00
VEON cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 100000000.00
VEON cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -24000000.00
VEON cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 30000000.00
VEON income_statement (quarterly, 2025-03-31) — Net Income: 99000000.00
VEON income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 99000000.00
VEON income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 118000000.00
VEON income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 99000000.00
VEON income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 99000000.00
VEON cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 130000000.00
VEON income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 118000000.00
VEON cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -36000000.00
VEON income_statement (quarterly, 2025-03-31) — Net Interest Income: -109000000.00
VEON cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
VEON cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -127000000.00
VEON cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -127000000.00
VEON income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -109000000.00
VEON cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -102000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Net PPE: 3109000000.00
VEON cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -172000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -270000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 394000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 16000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 394000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 16000000.00
VEON income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 479000000.00
VEON income_statement (quarterly, 2025-03-31) — Normalized Income: 128056000.00
VEON cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 433000000.00
VEON cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 30000000.00
VEON income_statement (quarterly, 2025-03-31) — Operating Income: 241000000.00
VEON income_statement (quarterly, 2025-03-31) — Operating Revenue: 1026000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 1752489609.00
VEON cash_flow (quarterly, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: 8000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 258000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 480000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -1967000000.00
VEON income_statement (quarterly, 2025-03-31) — Other Income Expense: -2000000.00
VEON cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 79000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 163000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 21000000.00
VEON income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 30000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 358000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Payables: 1514000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 1514000000.00
VEON income_statement (quarterly, 2025-03-31) — Pretax Income: 130000000.00
VEON cash_flow (quarterly, 2025-03-31) — Purchase Of Business: 0.00
VEON cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: -36000000.00
VEON cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
VEON cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -173000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Receivables: 569000000.00
VEON income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 129000000.00
VEON income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 198000000.00
VEON cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -216000000.00
VEON cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -24000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -3431000000.00
VEON cash_flow (quarterly, 2025-03-31) — Sale Of Business: 100000000.00
VEON cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 1000000.00
VEON income_statement (quarterly, 2025-03-31) — Selling General And Administration: 458000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Share Issued: 1849190667.00
VEON income_statement (quarterly, 2025-03-31) — Special Income Charges: -2000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1207000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -270000000.00
VEON income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -2944000.00
VEON income_statement (quarterly, 2025-03-31) — Tax Provision: 12000000.00
VEON income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.09
VEON balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 71000000.00
VEON cash_flow (quarterly, 2025-03-31) — Taxes Refund Paid: -70000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Total Assets: 8246000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 1207000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Total Debt: 4703000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1388000000.00
VEON income_statement (quarterly, 2025-03-31) — Total Expenses: 785000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 6858000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 5205000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 3095000000.00
VEON income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 239000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 169000000.00
VEON income_statement (quarterly, 2025-03-31) — Total Unusual Items: -32000000.00
VEON income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -32000000.00
VEON balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 96701058.00
VEON balance_sheet (quarterly, 2025-03-31) — Working Capital: -722000000.00
VEON income_statement (quarterly, 2025-03-31) — Write Off: 2000000.00
VEON income_statement (quarterly, 2025-06-30) — +Total Revenue: 1087000000.00
VEON balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1334000000.00
VEON balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 516000000.00
VEON income_statement (quarterly, 2025-06-30) — Amortization: 54000000.00
VEON income_statement (quarterly, 2025-06-30) — Amortization Of Intangibles Income Statement: 54000000.00
VEON balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 74000000.00
VEON income_statement (quarterly, 2025-06-30) — Basic Average Shares: 69640000.00
VEON income_statement (quarterly, 2025-06-30) — Basic EPS: 8.56
VEON cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 1773000000.00
VEON balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1282000000.00
VEON balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1282000000.00
VEON cash_flow (quarterly, 2025-06-30) — Changes In Cash: -488000000.00
VEON balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 1315000000.00
VEON balance_sheet (quarterly, 2025-06-30) — Current Assets: 2645000000.00
VEON balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 1061000000.00
VEON balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 3028000000.00
VEON income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 142000000.00
VEON income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 71840000.00
VEON income_statement (quarterly, 2025-06-30) — Diluted EPS: 8.30
VEON income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 608000000.00
VEON income_statement (quarterly, 2025-06-30) — EBIT: 800000000.00
VEON income_statement (quarterly, 2025-06-30) — EBITDA: 800000000.00
VEON cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -3000000.00
VEON cash_flow (quarterly, 2025-06-30) — End Cash Position: 1282000000.00
VEON cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -515000000.00
VEON cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 137000000.00
VEON income_statement (quarterly, 2025-06-30) — Gain On Sale Of Business: -498000000.00
VEON income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: -1000000.00
VEON balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 1553000000.00
VEON income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 1000000.00
VEON income_statement (quarterly, 2025-06-30) — Interest Expense: 118000000.00
VEON income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 118000000.00
VEON cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -110000000.00
VEON balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 3852000000.00
VEON income_statement (quarterly, 2025-06-30) — Net Income: 608000000.00
VEON income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 608000000.00
VEON income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 608000000.00
VEON income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 608000000.00
VEON income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 608000000.00
VEON income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 608000000.00
VEON balance_sheet (quarterly, 2025-06-30) — Net PPE: 3446000000.00
VEON balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -238000000.00
VEON income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 800000000.00
VEON income_statement (quarterly, 2025-06-30) — Normalized Income: 608000000.00
VEON cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 137000000.00
VEON income_statement (quarterly, 2025-06-30) — Operating Income: 820000000.00
VEON income_statement (quarterly, 2025-06-30) — Operating Revenue: 1087000000.00
VEON balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 1728844934.00
VEON cash_flow (quarterly, 2025-06-30) — Other Cash Adjustment Outside Changein Cash: 0.00
VEON balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 773000000.00
VEON balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 633000000.00
VEON balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 819000000.00
VEON balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 87000000.00
VEON balance_sheet (quarterly, 2025-06-30) — Payables: 1334000000.00
VEON balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 1334000000.00
VEON income_statement (quarterly, 2025-06-30) — Pretax Income: 682000000.00
VEON balance_sheet (quarterly, 2025-06-30) — Receivables: 516000000.00
VEON income_statement (quarterly, 2025-06-30) — Selling General And Administration: 462000000.00
VEON balance_sheet (quarterly, 2025-06-30) — Share Issued: 1849190667.00
VEON balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 1315000000.00
VEON balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -238000000.00
VEON income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
VEON income_statement (quarterly, 2025-06-30) — Tax Provision: 74000000.00
VEON income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.11
VEON balance_sheet (quarterly, 2025-06-30) — Total Assets: 8463000000.00
VEON balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 1315000000.00
VEON balance_sheet (quarterly, 2025-06-30) — Total Debt: 4913000000.00
VEON balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 1496000000.00
VEON balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 6967000000.00
VEON balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 5818000000.00
VEON balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 3939000000.00
VEON income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 820000000.00
VEON balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 120345733.00
VEON balance_sheet (quarterly, 2025-06-30) — Working Capital: -383000000.00
VEON income_statement (quarterly, 2025-06-30) — Write Off: 1000000.00
VEON income_statement (quarterly, 2025-09-30) — +Operating Expense: 825000000.00
VEON income_statement (quarterly, 2025-09-30) — +Total Revenue: 1115000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1256000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 549000000.00
VEON income_statement (quarterly, 2025-09-30) — Amortization: 55000000.00
VEON income_statement (quarterly, 2025-09-30) — Amortization Of Intangibles Income Statement: 55000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 1000000.00
VEON income_statement (quarterly, 2025-09-30) — Basic Average Shares: 68760000.00
VEON income_statement (quarterly, 2025-09-30) — Basic EPS: -1.91
VEON cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 1282000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1663000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1663000000.00
VEON cash_flow (quarterly, 2025-09-30) — Changes In Cash: 372000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 1466000000.00
VEON income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 133000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Current Assets: 2884000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1111000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 3043000000.00
VEON income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 205000000.00
VEON income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 205000000.00
VEON income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 150000000.00
VEON income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 71240000.00
VEON income_statement (quarterly, 2025-09-30) — Diluted EPS: -1.91
VEON income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -131000000.00
VEON income_statement (quarterly, 2025-09-30) — EBIT: 49000000.00
VEON income_statement (quarterly, 2025-09-30) — EBITDA: 254000000.00
VEON cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 3000000.00
VEON cash_flow (quarterly, 2025-09-30) — End Cash Position: 1663000000.00
VEON cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 211000000.00
VEON cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 323000000.00
VEON income_statement (quarterly, 2025-09-30) — Gain On Sale Of Business: -97000000.00
VEON income_statement (quarterly, 2025-09-30) — Gain On Sale Of Ppe: 1000000.00
VEON income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -7000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 1535000000.00
VEON income_statement (quarterly, 2025-09-30) — Gross Profit: 982000000.00
VEON income_statement (quarterly, 2025-09-30) — Interest Expense: 132000000.00
VEON income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 132000000.00
VEON cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -162000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 4032000000.00
VEON income_statement (quarterly, 2025-09-30) — Minority Interests: -4000000.00
VEON income_statement (quarterly, 2025-09-30) — Net Income: -131000000.00
VEON income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -131000000.00
VEON income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -127000000.00
VEON income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -131000000.00
VEON income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -131000000.00
VEON income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -127000000.00
VEON income_statement (quarterly, 2025-09-30) — Net Interest Income: -132000000.00
VEON income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -132000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Net PPE: 3566000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -69000000.00
VEON income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 360000000.00
VEON income_statement (quarterly, 2025-09-30) — Normalized Income: -55740000.00
VEON cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 323000000.00
VEON income_statement (quarterly, 2025-09-30) — Operating Income: 157000000.00
VEON income_statement (quarterly, 2025-09-30) — Operating Revenue: 1115000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 1724890109.00
VEON cash_flow (quarterly, 2025-09-30) — Other Cash Adjustment Outside Changein Cash: 6000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 671000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 676000000.00
VEON income_statement (quarterly, 2025-09-30) — Other Income Expense: -110000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 829000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 92000000.00
VEON income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -4000000.00
VEON income_statement (quarterly, 2025-09-30) — Other Operating Expenses: -13000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Payables: 1256000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 1256000000.00
VEON income_statement (quarterly, 2025-09-30) — Pretax Income: -83000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Receivables: 549000000.00
VEON income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 133000000.00
VEON income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 205000000.00
VEON income_statement (quarterly, 2025-09-30) — Selling General And Administration: 633000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Share Issued: 1849190667.00
VEON income_statement (quarterly, 2025-09-30) — Special Income Charges: -99000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 1466000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -69000000.00
VEON income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -30740000.00
VEON income_statement (quarterly, 2025-09-30) — Tax Provision: 44000000.00
VEON income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.29
VEON balance_sheet (quarterly, 2025-09-30) — Total Assets: 8814000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 1466000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Total Debt: 5143000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 1647000000.00
VEON income_statement (quarterly, 2025-09-30) — Total Expenses: 958000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 7167000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 5930000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 4124000000.00
VEON income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 59000000.00
VEON income_statement (quarterly, 2025-09-30) — Total Unusual Items: -106000000.00
VEON income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -106000000.00
VEON balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 124300558.00
VEON balance_sheet (quarterly, 2025-09-30) — Working Capital: -159000000.00
VEON income_statement (quarterly, 2025-09-30) — Write Off: 3000000.00
VEON income_statement (annual, 2025-12-31) — +Operating Expense: 2801000000.00
VEON income_statement (quarterly, 2025-12-31) — +Operating Expense: 662000000.00
VEON income_statement (annual, 2025-12-31) — +Total Revenue: 4399000000.00
VEON income_statement (quarterly, 2025-12-31) — +Total Revenue: 1171000000.00
VEON balance_sheet (annual, 2025-12-31) — Accounts Payable: 1442000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1442000000.00
VEON balance_sheet (annual, 2025-12-31) — Accounts Receivable: 249000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 249000000.00
VEON balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -3772000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -3772000000.00
VEON balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 12753000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 12753000000.00
VEON balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -85000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -85000000.00
VEON income_statement (annual, 2025-12-31) — Amortization: 224000000.00
VEON income_statement (quarterly, 2025-12-31) — Amortization: 55000000.00
VEON income_statement (annual, 2025-12-31) — Amortization Of Intangibles Income Statement: 224000000.00
VEON income_statement (quarterly, 2025-12-31) — Amortization Of Intangibles Income Statement: 55000000.00
VEON balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 0.00
VEON balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 0.00
VEON income_statement (annual, 2025-12-31) — Basic Average Shares: 69840000.00
VEON income_statement (annual, 2025-12-31) — Basic EPS: 7.50
VEON cash_flow (annual, 2025-12-31) — Beginning Cash Position: 1688000000.00
VEON cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 1663000000.00
VEON cash_flow (annual, 2025-12-31) — Capital Expenditure: -949000000.00
VEON balance_sheet (annual, 2025-12-31) — Capital Stock: 2000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Capital Stock: 2000000.00
VEON balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 1732000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 1732000000.00
VEON balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 2221000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 2221000000.00
VEON balance_sheet (annual, 2025-12-31) — Cash Equivalents: 1030000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 1030000000.00
VEON balance_sheet (annual, 2025-12-31) — Cash Financial: 702000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Cash Financial: 702000000.00
VEON cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -548000000.00
VEON cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -791000000.00
VEON cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 1353000000.00
VEON cash_flow (annual, 2025-12-31) — Cash Flow From Discontinued Operation: 14000000.00
VEON cash_flow (annual, 2025-12-31) — Cash From Discontinued Financing Activities: 0.00
VEON cash_flow (annual, 2025-12-31) — Cash From Discontinued Investing Activities: 0.00
VEON cash_flow (annual, 2025-12-31) — Cash From Discontinued Operating Activities: 0.00
VEON cash_flow (annual, 2025-12-31) — Change In Inventory: -16000000.00
VEON cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 96000000.00
VEON cash_flow (annual, 2025-12-31) — Change In Payable: 142000000.00
VEON cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 142000000.00
VEON cash_flow (annual, 2025-12-31) — Change In Receivables: -145000000.00
VEON cash_flow (annual, 2025-12-31) — Change In Working Capital: 77000000.00
VEON cash_flow (annual, 2025-12-31) — Changes In Cash: 28000000.00
VEON cash_flow (quarterly, 2025-12-31) — Changes In Cash: 73000000.00
VEON balance_sheet (annual, 2025-12-31) — Common Stock: 2000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Common Stock: 2000000.00
VEON balance_sheet (annual, 2025-12-31) — Common Stock Equity: 1340000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 1340000000.00
VEON cash_flow (annual, 2025-12-31) — Common Stock Issuance: 132000000.00
VEON cash_flow (annual, 2025-12-31) — Common Stock Payments: -105000000.00
VEON balance_sheet (annual, 2025-12-31) — Construction In Progress: 304000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 304000000.00
VEON income_statement (annual, 2025-12-31) — Cost Of Revenue: 526000000.00
VEON income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 160000000.00
VEON balance_sheet (annual, 2025-12-31) — Current Assets: 3113000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Current Assets: 3113000000.00
VEON balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1102000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1102000000.00
VEON balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 217000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 217000000.00
VEON balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 217000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 217000000.00
VEON balance_sheet (annual, 2025-12-31) — Current Liabilities: 3436000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 3436000000.00
VEON balance_sheet (annual, 2025-12-31) — Current Provisions: 261000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Current Provisions: 261000000.00
VEON cash_flow (annual, 2025-12-31) — Depreciation: 811000000.00
VEON cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 811000000.00
VEON income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 802000000.00
VEON income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 204000000.00
VEON cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 811000000.00
VEON income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 802000000.00
VEON income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 204000000.00
VEON income_statement (annual, 2025-12-31) — Depreciation Income Statement: 578000000.00
VEON income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 149000000.00
VEON income_statement (annual, 2025-12-31) — Diluted Average Shares: 71760000.00
VEON income_statement (annual, 2025-12-31) — Diluted EPS: 7.50
VEON income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 532000000.00
VEON income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -31000000.00
VEON income_statement (annual, 2025-12-31) — EBIT: 1320000000.00
VEON income_statement (quarterly, 2025-12-31) — EBIT: 233000000.00
VEON income_statement (annual, 2025-12-31) — EBITDA: 2131000000.00
VEON income_statement (quarterly, 2025-12-31) — EBITDA: 437000000.00
VEON cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 16000000.00
VEON cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 10000000.00
VEON cash_flow (annual, 2025-12-31) — End Cash Position: 1732000000.00
VEON cash_flow (quarterly, 2025-12-31) — End Cash Position: 1732000000.00
VEON cash_flow (annual, 2025-12-31) — Financing Cash Flow: -548000000.00
VEON cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -93000000.00
VEON balance_sheet (annual, 2025-12-31) — Foreign Currency Translation Adjustments: -6309000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Foreign Currency Translation Adjustments: -6309000000.00
VEON cash_flow (annual, 2025-12-31) — Free Cash Flow: 404000000.00
VEON cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -487000000.00
VEON cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: -400000000.00
VEON income_statement (annual, 2025-12-31) — Gain On Sale Of Business: 400000000.00
VEON income_statement (quarterly, 2025-12-31) — Gain On Sale Of Business: -1000000.00
VEON income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 2000000.00
VEON income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: 1000000.00
VEON income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -18000000.00
VEON income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 40000000.00
VEON balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -8417000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -8417000000.00
VEON income_statement (annual, 2025-12-31) — General And Administrative Expense: 1798000000.00
VEON balance_sheet (annual, 2025-12-31) — Goodwill: 399000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Goodwill: 399000000.00
VEON balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 1549000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 1549000000.00
VEON balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 334000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 334000000.00
VEON balance_sheet (annual, 2025-12-31) — Gross PPE: 7529000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Gross PPE: 7529000000.00
VEON income_statement (annual, 2025-12-31) — Gross Profit: 3873000000.00
VEON income_statement (quarterly, 2025-12-31) — Gross Profit: 1011000000.00
VEON balance_sheet (annual, 2025-12-31) — Income Tax Payable: 88000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 88000000.00
VEON income_statement (annual, 2025-12-31) — Interest Expense: 535000000.00
VEON income_statement (quarterly, 2025-12-31) — Interest Expense: 177000000.00
VEON income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 535000000.00
VEON income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 177000000.00
VEON income_statement (annual, 2025-12-31) — Interest Income: 52000000.00
VEON income_statement (annual, 2025-12-31) — Interest Income Non Operating: 52000000.00
VEON cash_flow (annual, 2025-12-31) — Interest Paid Cfo: -399000000.00
VEON cash_flow (annual, 2025-12-31) — Interest Received Cfo: 44000000.00
VEON balance_sheet (annual, 2025-12-31) — Inventory: 32000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Inventory: 32000000.00
VEON balance_sheet (annual, 2025-12-31) — Invested Capital: 1340000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Invested Capital: 1340000000.00
VEON cash_flow (annual, 2025-12-31) — Investing Cash Flow: -791000000.00
VEON cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -310000000.00
VEON balance_sheet (annual, 2025-12-31) — Investments And Advances: 144000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 144000000.00
VEON cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 132000000.00
VEON cash_flow (annual, 2025-12-31) — Issuance Of Debt: 971000000.00
VEON balance_sheet (annual, 2025-12-31) — Loans Receivable: 335000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Loans Receivable: 335000000.00
VEON balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 4043000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 4043000000.00
VEON cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 971000000.00
VEON cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -1546000000.00
VEON balance_sheet (annual, 2025-12-31) — Long Term Provisions: 43000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 43000000.00
VEON balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 422000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 422000000.00
VEON balance_sheet (annual, 2025-12-31) — Minority Interest: 294000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Minority Interest: 294000000.00
VEON income_statement (annual, 2025-12-31) — Minority Interests: -59000000.00
VEON income_statement (quarterly, 2025-12-31) — Minority Interests: -23000000.00
VEON cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 284000000.00
VEON cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 27000000.00
VEON cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 41000000.00
VEON income_statement (annual, 2025-12-31) — Net Income: 532000000.00
VEON income_statement (quarterly, 2025-12-31) — Net Income: -31000000.00
VEON income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 532000000.00
VEON income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -31000000.00
VEON income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 591000000.00
VEON income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -8000000.00
VEON income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: 0.00
VEON income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 532000000.00
VEON income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -31000000.00
VEON income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 532000000.00
VEON income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -31000000.00
VEON cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 785000000.00
VEON income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 591000000.00
VEON income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -8000000.00
VEON cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -216000000.00
VEON income_statement (annual, 2025-12-31) — Net Interest Income: -483000000.00
VEON income_statement (quarterly, 2025-12-31) — Net Interest Income: -125000000.00
VEON cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 23000000.00
VEON cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -575000000.00
VEON cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -575000000.00
VEON income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -483000000.00
VEON income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -125000000.00
VEON cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -159000000.00
VEON balance_sheet (annual, 2025-12-31) — Net PPE: 3757000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Net PPE: 3757000000.00
VEON cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -723000000.00
VEON balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -209000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -209000000.00
VEON balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 512000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 512000000.00
VEON balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 48000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 48000000.00
VEON balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 7000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 7000000.00
VEON balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 418000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 418000000.00
VEON balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 41000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 41000000.00
VEON balance_sheet (annual, 2025-12-31) — Non Current Note Receivables: 31000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Non Current Note Receivables: 31000000.00
VEON balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 24000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 24000000.00
VEON income_statement (annual, 2025-12-31) — Normalized EBITDA: 1931000000.00
VEON income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 575000000.00
VEON income_statement (annual, 2025-12-31) — Normalized Income: 381400000.00
VEON income_statement (quarterly, 2025-12-31) — Normalized Income: 66980000.00
VEON cash_flow (annual, 2025-12-31) — Operating Cash Flow: 1353000000.00
VEON cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 462000000.00
VEON cash_flow (annual, 2025-12-31) — Operating Gains Losses: -361000000.00
VEON income_statement (annual, 2025-12-31) — Operating Income: 1072000000.00
VEON income_statement (quarterly, 2025-12-31) — Operating Income: 349000000.00
VEON income_statement (annual, 2025-12-31) — Operating Revenue: 4399000000.00
VEON income_statement (quarterly, 2025-12-31) — Operating Revenue: 1171000000.00
VEON balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 1719186734.00
VEON balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 1719186734.00
VEON balance_sheet (annual, 2025-12-31) — Other Current Assets: 30000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 30000000.00
VEON balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 144000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 144000000.00
VEON balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -2108000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -2108000000.00
VEON income_statement (annual, 2025-12-31) — Other Gand A: 1317000000.00
VEON income_statement (annual, 2025-12-31) — Other Income Expense: 196000000.00
VEON income_statement (quarterly, 2025-12-31) — Other Income Expense: -169000000.00
VEON balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 1150000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 1150000000.00
VEON cash_flow (annual, 2025-12-31) — Other Non Cash Items: 775000000.00
VEON balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 85000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 85000000.00
VEON balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 11000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 11000000.00
VEON income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -4000000.00
VEON income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -31000000.00
VEON income_statement (annual, 2025-12-31) — Other Operating Expenses: 142000000.00
VEON income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 155000000.00
VEON balance_sheet (annual, 2025-12-31) — Other Payable: 53000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Other Payable: 53000000.00
VEON balance_sheet (annual, 2025-12-31) — Other Properties: 6593000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Other Properties: 6593000000.00
VEON balance_sheet (annual, 2025-12-31) — Other Receivables: 17000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Other Receivables: 17000000.00
VEON balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 489000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 489000000.00
VEON income_statement (annual, 2025-12-31) — Other Special Charges: 149000000.00
VEON income_statement (annual, 2025-12-31) — Other Taxes: 59000000.00
VEON balance_sheet (annual, 2025-12-31) — Payables: 1712000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Payables: 1712000000.00
VEON balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 1712000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 1712000000.00
VEON balance_sheet (annual, 2025-12-31) — Prepaid Assets: 136000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 136000000.00
VEON income_statement (annual, 2025-12-31) — Pretax Income: 785000000.00
VEON income_statement (quarterly, 2025-12-31) — Pretax Income: 56000000.00
VEON balance_sheet (annual, 2025-12-31) — Properties: 210000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Properties: 210000000.00
VEON cash_flow (annual, 2025-12-31) — Purchase Of Business: -157000000.00
VEON cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -216000000.00
VEON cash_flow (annual, 2025-12-31) — Purchase Of PPE: -733000000.00
VEON balance_sheet (annual, 2025-12-31) — Receivables: 694000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Receivables: 694000000.00
VEON income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 517000000.00
VEON income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 160000000.00
VEON income_statement (annual, 2025-12-31) — Reconciled Depreciation: 811000000.00
VEON income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 204000000.00
VEON cash_flow (annual, 2025-12-31) — Repayment Of Debt: -1546000000.00
VEON cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -105000000.00
VEON balance_sheet (annual, 2025-12-31) — Retained Earnings: -2998000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -2998000000.00
VEON income_statement (annual, 2025-12-31) — Salaries And Wages: 481000000.00
VEON cash_flow (annual, 2025-12-31) — Sale Of Business: 441000000.00
VEON cash_flow (annual, 2025-12-31) — Sale Of PPE: 10000000.00
VEON income_statement (annual, 2025-12-31) — Selling General And Administration: 1798000000.00
VEON income_statement (quarterly, 2025-12-31) — Selling General And Administration: 244000000.00
VEON balance_sheet (annual, 2025-12-31) — Share Issued: 1849190667.00
VEON balance_sheet (quarterly, 2025-12-31) — Share Issued: 1849190667.00
VEON income_statement (annual, 2025-12-31) — Special Income Charges: 218000000.00
VEON income_statement (quarterly, 2025-12-31) — Special Income Charges: -178000000.00
VEON balance_sheet (annual, 2025-12-31) — Stockholders Equity: 1340000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 1340000000.00
VEON balance_sheet (annual, 2025-12-31) — Tangible Book Value: -209000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -209000000.00
VEON income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 49400000.00
VEON income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -40020000.00
VEON income_statement (annual, 2025-12-31) — Tax Provision: 194000000.00
VEON income_statement (quarterly, 2025-12-31) — Tax Provision: 64000000.00
VEON income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.25
VEON income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.29
VEON balance_sheet (annual, 2025-12-31) — Taxes Receivable: 93000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 93000000.00
VEON cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -379000000.00
VEON balance_sheet (annual, 2025-12-31) — Total Assets: 9215000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Total Assets: 9215000000.00
VEON balance_sheet (annual, 2025-12-31) — Total Capitalization: 1340000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 1340000000.00
VEON balance_sheet (annual, 2025-12-31) — Total Debt: 5145000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Total Debt: 5145000000.00
VEON balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 1634000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 1634000000.00
VEON income_statement (annual, 2025-12-31) — Total Expenses: 3327000000.00